Radiofrequency ablation: a novel approach for treatment of metastatic pheochromocytoma.
作者信息
Pacak K, Fojo T, Goldstein D S, Eisenhofer G, Walther M M, Linehan W M, Bachenheimer L, Abraham J, Wood B J
出版信息
J Natl Cancer Inst. 2001 Apr 18;93(8):648-9. doi: 10.1093/jnci/93.8.648.
Abstract
摘要
相似文献
1
Radiofrequency ablation: a novel approach for treatment of metastatic pheochromocytoma.
J Natl Cancer Inst. 2001 Apr 18;93(8):648-9. doi: 10.1093/jnci/93.8.648.
2
Radiofrequency ablation of metastatic pheochromocytoma.
J Vasc Interv Radiol. 2009 Nov;20(11):1483-90. doi: 10.1016/j.jvir.2009.07.031.
3
Malignant pheochromocytoma. Diffuse skeletal metastases manifested by I-123-metaiodobenzylguanidine scintigraphy.
Clin Nucl Med. 1993 Feb;18(2):166-7. doi: 10.1097/00003072-199302000-00023.
4
Metastatic pheochromocytoma: "cold" lesions in bone scan.
Bol Asoc Med P R. 1983 Jul;75(7):315-6.
5
[Use of 131-metaiodobenzylguanidine in the diagnosis and treatment of malignant pheochromocytomas].
Med Clin (Barc). 1986 Sep 20;87(8):330-3.
6
Minimally invasive treatment of metastatic pheochromocytoma and paraganglioma: efficacy and safety of radiofrequency ablation and cryoablation therapy.
J Vasc Interv Radiol. 2011 Sep;22(9):1263-70. doi: 10.1016/j.jvir.2011.06.016.
7
Improved detection of disseminated pheochromocytoma using post therapy I-131 MIBG scanning.
Clin Nucl Med. 1996 Dec;21(12):960-3. doi: 10.1097/00003072-199612000-00009.
8
Malignant pheochromocytoma lacking clinical features of catecholamine excess until the late stage.
Intern Med. 2000 Oct;39(10):820-5. doi: 10.2169/internalmedicine.39.820.
9
Radiofrequency ablation for adrenal lesions.
Curr Urol Rep. 2006 Jan;7(1):68. doi: 10.1007/s11934-006-0043-8.
10
Iodine-131 MIBG scintigraphy of the extremities in metastatic pheochromocytoma and neuroblastoma.
J Nucl Med. 1987 Mar;28(3):315-8.
引用本文的文献
1
Editorial: Functional neuroendocrine tumors.
Front Endocrinol (Lausanne). 2025 Jul 23;16:1662247. doi: 10.3389/fendo.2025.1662247. eCollection 2025.
2
International consensus statement on the diagnosis and management of phaeochromocytoma and paraganglioma in children and adolescents.
Nat Rev Endocrinol. 2024 Dec;20(12):729-748. doi: 10.1038/s41574-024-01024-5. Epub 2024 Aug 15.
3
Management of phaeochromocytoma and paraganglioma in patients with germline SDHB pathogenic variants: an international expert Consensus statement.
Nat Rev Endocrinol. 2024 Mar;20(3):168-184. doi: 10.1038/s41574-023-00926-0. Epub 2023 Dec 14.
4
Image-Guided Precision Medicine in the Diagnosis and Treatment of Pheochromocytomas and Paragangliomas.
Cancers (Basel). 2023 Sep 21;15(18):4666. doi: 10.3390/cancers15184666.
5
Irreversible electroporation treatment of pheochromocytoma at a complex site: A case report.
J Interv Med. 2020 Apr 8;3(2):101-105. doi: 10.1016/j.jimed.2020.03.009. eCollection 2020 May.
6
Efficacy and Safety of Ablative Therapy in the Treatment of Patients with Metastatic Pheochromocytoma and Paraganglioma.
Cancers (Basel). 2019 Feb 7;11(2):195. doi: 10.3390/cancers11020195.
7
Multimodal Somatostatin Receptor Theranostics Using [(64)Cu]Cu-/[(177)Lu]Lu-DOTA-(Tyr(3))octreotate and AN-238 in a Mouse Pheochromocytoma Model.
Theranostics. 2016 Mar 10;6(5):650-65. doi: 10.7150/thno.14479. eCollection 2016.
8
Successful Treatment of Coexisting Paraganglioma of the Retroperitoneum and Urinary Bladder by Intermediate-Dose 131I-MIBG Therapy: A Case Report.
Medicine (Baltimore). 2015 Oct;94(41):e1686. doi: 10.1097/MD.0000000000001686.
9
In vivo fluorescence imaging and urinary monoamines as surrogate biomarkers of disease progression in a mouse model of pheochromocytoma.
Endocrinology. 2014 Nov;155(11):4149-56. doi: 10.1210/en.2014-1431. Epub 2014 Aug 19.
10
Pheochromocytoma and paraganglioma: diagnosis, genetics, management, and treatment.
Curr Probl Cancer. 2014 Jan-Feb;38(1):7-41. doi: 10.1016/j.currproblcancer.2014.01.001. Epub 2014 Jan 15.
本文引用的文献
1
Percutaneous radiofrequency (RF) ablation therapy for hepatocellular carcinoma: difficulty in removing the expandable RF needle electrode.
AJR Am J Roentgenol. 2000 Jan;174(1):264-5. doi: 10.2214/ajr.174.1.1740264a.
2
Percutaneous radiofrequency ablation of malignancies in the lung.
AJR Am J Roentgenol. 2000 Jan;174(1):57-9. doi: 10.2214/ajr.174.1.1740057.
3
Radiofrequency ablation of breast cancer: first report of an emerging technology.
Arch Surg. 1999 Oct;134(10):1064-8. doi: 10.1001/archsurg.134.10.1064.
4
Percutaneous transperineal radiofrequency ablation of prostate tumour: safety, feasibility and pathological effects on human prostate cancer.
Br J Urol. 1998 Feb;81(2):265-75. doi: 10.1046/j.1464-410x.1998.00504.x.
Zotero 插件